ABOUT US

HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.

founded

investments completed

employees

million annual revenue

Learn more

PORTFOLIO

Our portfolio size is intentionally small so we can dedicate the time and effort 
required to customize our investment strategy to address the specific needs of each company. Through these investments, we create scalable, revenue-generating 
entities with multiple exit alternatives.

Cheetah Medical
Tela Bio
Aziyo Biologics
Zipline
Read more

CASE STUDIES

We are passionate about building companies and have a track record of success in delivering value to our investment partners and the healthcare system. See how our investment strategy has transformed companies and realized outsized returns.

Case Studies

LATEST NEWS

Nora Brennan Joins TELA Bio® as Chief Financial Officer read more
Aziyo’s CanGaroo Envelope Cleared for Expanded Use with Neurostimulator Devices read more
ZipLine Medical Announces Publication of Two Clinical Studies Demonstrating Superior Infection Protection and 22 Percent Reduction in Procedure Time with Zip Surgical Skin Closure read more
TELA Bio® Appoints Kurt Azarbarzin to Board of Directors read more
title read more
See more articles

CONTACT US

Could HighCape be the right partner for your growing business?
Contact us for more information.

452 5th Ave, 21st Floor
New York, NY 10018